In acute myeloid tumors, KIT is overexpressed in most pediatric AML karyotypes (excluding AML with KMT2A-rearrangement) compared to CML or normal bone marrow (Figure 1B). The gene discussed is KIT; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.